Effects of Nutritional Supplementation of Leucine and Polyunsaturated Fatty Acids on Muscle Health in the Elderly
Recruiting
N/A
Interventional Study
Sarcopenia
Sarcopenia in Elderly
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 50 – 99
- Sex
- Any
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 90 (estimated)
- Sponsor
- Chang Gung Memorial Hospital · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Population aging has become a significant global concern, and Taiwan is set to officially enter the "super-aged society" in 2025. As individuals age, various physiological functions gradually decline, including a reduction in muscle mass, which is a key aspect of the aging process.
This interventional study aims to investigate the effects of leucine-rich protein combined with polyunsaturated fatt…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Age ≥ 50 years
* ASMI \< 7 kg/m2 in men
* ASMI \< 5.7 kg/m2 in women
* Grip strength \< 28 kg in men
* Grip strength \< 18 kg in women
* Walk speed \< 1 m/s
Exclusion Criteria:
* People who are allergic to supplements
* cancer
* heart failure
* kidney disease
* autoimmune di…
Contacts